Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN.

Disease models & mechanisms·2016
Same author

Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling.

Oncogene·2015
Same author

Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation.

Cell death and differentiation·2015

相关实验视频

Updated: Jul 6, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

与Ha-Ras的致癌和转录合作需要对c-Jun在63和73级蛋白上进行酸化.

T Smeal1, B Binetruy, D A Mercola

  • 1Department of Pharmacology, University of California San Diego, School of Medicine, La Jolla 92093-0636.

Nature
|December 12, 1991
PubMed
概括

瘤性Ha-ras信号激活AP-1复合体,通过酸化c-Jun在63和73级蛋白中进行激活. 这种酸化对于Ha-ras诱导的细胞转化和基因表达变化至关重要.

科学领域:

  • 分子生物学分子生物学
  • 细胞信号传输 细胞信号传输
  • 在瘤学瘤学.

背景情况:

  • 瘤促进剂,转化和激活蛋白-1 (AP-1) 的活性是相关的.
  • 蛋白激酶C激活和生长因子刺激AP-1的DNA结合活性.
  • 由Jun和Fos蛋白组成的AP-1复合体是信号级联的核心.

研究的目的:

  • 调查c-Jun作为瘤信号的目标的作用.
  • 阐明Ha-ras如何影响c-Jun的活动和转变.
  • 为了绘制由Ha-ras.调节的c-Jun上特定的酸化点的地图.

主要方法:

  • 研究了蛋白激酶C激活及其对AP-1DNA结合的影响.
  • 使用大鼠胚胎纤维细胞进行转化测试,使用c-Jun和Ha-ras.
  • 采用位点定向突变发生法来识别和分析c-Jun的酸化位点.

主要成果:

  • 纤维细胞的瘤转化需要功能性c-Jun转录活动.
  • 致癌性Ha-ras的表达增强了c-Jun的交换活化,并刺激了其酸化.
  • 在c-Jun上的酸化部位,特别是63和73,被绘制为Ha-ras-responsive.

更多相关视频

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

相关实验视频

Last Updated: Jul 6, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

结论:

  • 哈拉斯对c-Jun在63和73级的酸化对其增强的活性至关重要.
  • 这种酸化对于Ha-ras与c-Jun在瘤转化中的合作至关重要.
  • c-Jun作为一个关键的调解者,将瘤信号转化为改变基因表达的转化.